Cargando…
Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS
CONTEXT: Women with polycystic ovary syndrome (PCOS) have an increased risk of cardiovascular disease (CVD), and biomarkers can be used to detect early subclinical CVD. Midregional-pro-adrenomedullin (MR-proADM), midregional-pro-atrial natriuretic peptide (MR-proANP) and copeptin are all associated...
Autores principales: | Frøssing, Signe, Nylander, Malin, Kistorp, Caroline, Skouby, Sven O, Faber, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754509/ https://www.ncbi.nlm.nih.gov/pubmed/29295870 http://dx.doi.org/10.1530/EC-17-0327 |
Ejemplares similares
-
Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential
por: Nylander, Malin, et al.
Publicado: (2017) -
Copeptin, pro-atrial natriuretic peptide and pro-adrenomedullin as markers of hypoxic stress in patients with obstructive sleep apnea—a prospective intervention study
por: Karakioulaki, Meropi, et al.
Publicado: (2021) -
Cardiac natriuretic peptides in plasma increase after dietary induced weight loss in obesity
por: Kistorp, Caroline, et al.
Publicado: (2014) -
Prognostic value of pro-adrenomedullin and copeptin in acute infective endocarditis
por: Zampino, Rosa, et al.
Publicado: (2021) -
Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH
por: Kriechbaum, Steffen D., et al.
Publicado: (2020)